Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project.
Bria MidgetteAndrew StrunkOleg AkilovAfsaneh AlaviChristine ArdonFalk G BecharaArnon D CohenSteven B CohenSteven DaveluyVéronique Del MarmolMaïa DelageSolveig EsmannShani FisherEvangelos J Giamarellos-BourboulisAmelia GlowaczewskaNoah GoldfarbElena Gonzalez BrantØystein GrimstadSandra GuilbaultIltefat HamzaviRosalind HughesJohn R IngramGregor Borut Ernst JemecQiang JuNaomi KappeBrian KirbyJoslyn S KirbyMichelle A LowesLukasz MatusiakStella MichaRobert G MichelettiAngela P MillerDagfinn MosengHaley B NaikAude NassifGeorgios NikolakisSo Yeon PaekJose Carlos PascualErrol PrensBarry ResnikHassan RiadChristopher J SayedSaxon D SmithYssra SolimanJacek Cezary SzepietowskiJerry TanLinnea ThorlaciusThrasyvoulos TzellosHessel H van der ZeeBente VillumsenLanqi WangChristos ZouboulisAmit GargPublished in: The British journal of dermatology (2022)
There are several factors that appear to positively influence satisfaction with treatment among patients with HS, including treatment by a dermatologist and treatment with a biologic medication. Factors that appear to lower treatment satisfaction include active smoking, depression, accumulation of comorbid conditions and increasing flare frequency. Awareness of these factors may support partnered decision making with the goal of improving treatment outcomes. What is already known about this topic? Nearly half of patients with hidradenitis suppurativa report dissatisfaction with their treatments. What does this study add? Satisfaction with treatment is increased by receiving care from a dermatologist and treatment with biologics. Satisfaction with treatment is decreased by tobacco smoking, accumulation of comorbid conditions including depression, and higher flare frequency. What are the clinical implications of this work? Awareness of the identified factors associated with poor treatment satisfaction may support partnered decision making and improve treatment outcomes.